NeoGenomics
NEO
NEO
311 hedge funds and large institutions have $5.02B invested in NeoGenomics in 2021 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 107 increasing their positions, 104 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
6% less funds holding
Funds holding: 332 → 311 (-21)
35% less first-time investments, than exits
New positions opened: 33 | Existing positions closed: 51
40% less funds holding in top 10
Funds holding in top 10: 10 → 6 (-4)
Holders
311
Holding in Top 10
6
Calls
$11M
Puts
$6.77M
Top Buyers
| 1 | +$61.7M | |
| 2 | +$53.9M | |
| 3 | +$39.2M | |
| 4 |
BWLSA
Blue Water Life Science Advisors
Larkspur,
California
|
+$31.7M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$29M |
Top Sellers
| 1 | -$34.6M | |
| 2 | -$17.4M | |
| 3 | -$14.9M | |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$14M |
| 5 |
FAM
Fred Alger Management
New York
|
-$9.89M |